Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

Walgreens Boots Alliance Inc Stock , WBA

11.01 +0.02 +0.18%
Pre-market 08:40:10 AM BTT
Plus500. 80% of retail CFD accounts lose money
10.99 -0.37 -3.26%
Official Close 03:59:59 PM EDT 7/19/2024 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Friday 07/19/2024 the closing price of the Walgreens Boots Alliance Inc share was $10.99 on BTT. Compared to the opening price on Friday 07/19/2024 on BTT of $11.47, this is a drop of 4.37%. Walgreens Boots Alliance Inc's market capitalization is $9.51 B by 863.28 M shares outstanding.
Is Walgreens Boots Alliance stock a Buy, Sell or Hold? Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 6 buy ratings, 35 hold ratings, and 12 sell ratings.
What was the 52-week low for Walgreens Boots Alliance stock? The low in the last 52 weeks of Walgreens Boots Alliance stock was 10.69. According to the current price, Walgreens Boots Alliance is 102.99% away from the 52-week low.
What was the 52-week high for Walgreens Boots Alliance stock? The high in the last 52 weeks of Walgreens Boots Alliance stock was 31.32. According to the current price, Walgreens Boots Alliance is 35.16% away from the 52-week high.
What are analysts forecasts for Walgreens Boots Alliance stock? The 53 analysts offering price forecasts for Walgreens Boots Alliance have a median target of 29.94, with a high estimate of 54.00 and a low estimate of 9.00. The median estimate represents a 36.77 difference from the last price of 11.01.

Walgreens Boots Alliance Stock Snapshot

11.00
Bid
10.00
Bid Size
11.02
Ask
200.00
Ask Size
7/22/2024
Date
8:40 AM
Time
1,002.00
Volume
10.99
Prev. Close
11.05
Open
9.49 B
Market Cap in USD
863.28 M
Number of Shares
11.01
Day Low
11.05
Day High
11.01
10.69
52 Week Low
31.32
52 Week High
11.01
1.92
Dividend in USD
7.59
Dividend Yield
82.43
Free Float in %
-3.57
EPS in USD
23.18
Book Value per Share in USD
2.61
Cash Flow per Share in USD
Trade Now

Historical Prices for Walgreens Boots Alliance

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Walgreens Boots Alliance Analyst Data

Total Analysts: 53
Buy Ratings: 6 Neutral Ratings: 35 Sell Ratings: 12
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 9.00 Median: 29.94 Highest: 54.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Walgreens Boots Alliance Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
07/03/24 UBS
Maintained Hold $12
07/02/24 RBC Capital Markets
Maintained Hold $13
07/01/24 J.P. Morgan
Maintained Buy $20
06/28/24 Barclays Capital
Maintained Sell $11
06/28/24 Morgan Stanley
Maintained Sell $9
06/28/24 Bank of America Merrill Lynch
Maintained Sell $11
06/28/24 Evercore
Maintained Hold $10
06/24/24 UBS
Maintained Hold $17
06/24/24 Barclays Capital
Maintained Sell $19
06/03/24 Evercore
Maintained Hold $17
05/31/24 Morgan Stanley
Maintained Sell $13
04/03/24 Deutsche Bank
Maintained Hold $22
04/03/24 UBS
Maintained Hold $22
04/01/24 Morgan Stanley
Maintained Sell $20
03/26/24 Raymond James Financial, Inc.
Maintained Hold
03/26/24 Morgan Stanley
Maintained Sell $21
03/26/24 Bank of America Merrill Lynch
Maintained Sell $22
02/20/24 HSBC
Downgraded to Sell $20
12/22/23 HSBC
Maintained Sell $27
10/23/23 J.P. Morgan
Upgraded to Buy $30
10/13/23 RBC Capital Markets
Maintained Hold $26
10/10/23 Mizuho
Maintained Hold $25
10/05/23 J.P. Morgan
Maintained Hold $27
09/22/23 Deutsche Bank
Maintained Hold $27
08/24/23 Credit Suisse
Maintained Hold $30
07/14/23 Mizuho
Maintained Hold $31
06/29/23 RBC Capital Markets
Maintained Hold $29
06/28/23 Mizuho
Maintained Hold $35
06/28/23 J.P. Morgan
Maintained Hold $35
06/28/23 Barclays Capital
Maintained Hold $32
06/28/23 Credit Suisse
Maintained Hold $33
06/28/23 Deutsche Bank
Downgraded to Hold $34
06/26/23 Morgan Stanley
Maintained Sell $37
06/13/23 Mizuho
Maintained Hold $35
03/30/23 Deutsche Bank
Maintained Buy $46
03/29/23 UBS
Maintained Hold $37
03/29/23 Mizuho
Maintained Hold $41
03/29/23 J.P. Morgan
Maintained Hold $43
03/27/23 Barclays Capital
Maintained Hold $43
03/22/23 Evercore
Maintained Hold $35
02/23/23 Loop Capital
Maintained Buy $45
01/30/23 Morgan Stanley
Maintained Sell $37
01/06/23 J.P. Morgan
Maintained Hold $40
01/06/23 Credit Suisse
Maintained Hold $41
12/14/22 Mizuho
Maintained Hold $41
11/22/22 Cowen and Company, LLC
Upgraded to Buy $54
11/18/22 J.P. Morgan
Upgraded to Buy
11/11/22 Deutsche Bank
Upgraded to Buy $50
10/25/22 Deutsche Bank
Maintained Hold $41
10/19/22 RBC Capital Markets
Maintained Hold $36

Walgreens Boots Alliance Estimates* in USD

  2024 2025 2026 2027 2028
Revenue 145,832 147,828 151,838 155,611 161,228
Dividend 1.45 1.20 0.91 - -
Dividend Yield (in %) 13.14 % 10.86 % 8.29 % - -
EPS 2.87 2.18 2.29 2.52 2.92
P/E Ratio 3.84 5.07 4.82 4.39 3.79
EBIT 2,692 2,413 2,643 3,036 3,482
EBITDA 4,348 3,857 4,238 3,959 4,137
Net Profit 2,493 1,843 2,001 2,191 2,544
Net Profit Adjusted 2,493 1,843 2,001 2,191 2,544
Pre-Tax Profit 2,262 2,072 2,198 2,668 3,145
Net Profit (Adjusted) - 1,535 1,866 - -
EPS (Non-GAAP) ex. SOE 2.69 1.99 2.15 2.76 3.41
EPS (GAAP) -6.44 0.59 1.46 1.07 1.47
Gross Income 26,836 26,566 27,090 28,635 29,970
Cash Flow from Investing -3,346 -1,444 -1,792 -996 -976
Cash Flow from Operations 1,003 2,122 3,151 3,370 3,911
Cash Flow from Financing -3,346 -1,444 -1,792 -996 -976
Cash Flow per Share 3.35 3.07 3.83 - -
Free Cash Flow -535 586 1,615 1,671 2,150
Free Cash Flow per Share - - - - -
Book Value per Share 14.80 14.83 15.76 - -
Net Debt 7,300 6,736 5,717 - -
Research & Development Exp. - - - - -
Capital Expenditure 1,237 1,606 1,670 1,698 1,760
Selling, General & Admin. Exp. 29,095 25,166 25,387 26,388 27,268
Shareholder’s Equity 13,354 13,119 13,474 15,883 16,725
Total Assets 83,363 82,508 82,627 82,220 82,752
  Previous Quarter
ending 06/30/24 		Current Quarter
ending 09/30/24 		Next Quarter
ending 12/31/24 		Current Year
ending 08/31/24 		Next Year
ending 08/31/25
Earnings Estimates
No. of Analysts - - - 17 16
Average Estimate - - - 2.874 USD 2.179 USD
Year Ago - - - -3.568 USD -
Publish Date - - - - -
Revenue Estimates
No. of Analysts - - - 14 13
Average Estimate - - - 145,832 USD 147,828 USD
Year Ago - - - 139,081 USD -
Publish Date - - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Sales 139,081.00 132,703.00 132,509.00 139,537.00 136,866.00 131,537.00 118,214.00
Change of sales in % 4.81 0.15 -5.04 1.95 4.05 11.27 0.74
Gross profit on sales 24,815.00 26,275.00 26,144.00 26,090.00 28,038.00 29,022.00 27,508.00
Gross profit on sales change in % -5.56 0.50 0.21 -6.95 -3.39 5.50 -2.30
Operating income 2,987.00 2,771.00 4,018.00 3,747.00 5,127.00 6,306.00 6,260.00
Operating income change in % 7.80 -31.04 7.23 -26.92 -18.70 0.73 -1.71
Income before tax -5,419.00 3,985.00 1,995.00 743.00 4,527.00 5,975.00 4,853.00
Income before tax change in % - 99.75 168.51 -83.59 -24.23 23.12 -5.66
Income after tax -3,080.00 4,336.00 2,220.00 456.00 3,982.00 5,024.00 4,078.00
Income after tax change in % - 95.32 386.84 -88.55 -20.74 23.20 -2.28

Balance Sheet in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Total liabilities 68,140.00 59,716.00 57,145.00 66,038.00 43,445.00 41,435.00 37,735.00
Long-term liabilities per share 50.49 42.95 40.55 45.02 19.74 20.76 18.74
Equity 28,489.00 30,408.00 24,140.00 21,135.00 24,153.00 26,689.00 28,274.00
Equity change in % -20.79 7.93 13.48 -12.23 -9.59 -5.31 -8.08
Balance sheet total 96,629.00 90,124.00 81,285.00 87,173.00 67,598.00 68,124.00 66,009.00
Balance sheet total change in % 7.22 10.87 -6.75 28.96 -0.77 3.20 -9.19

Key Data in USD

2023 2022 2021 2020 2019 2018 2017
Sales per share 161.12 153.25 152.94 158.51 148.20 132.20 109.61
P/E ratio (year end quote, basic EPS) - 7.00 19.81 73.40 11.87 13.58 21.56
P/E ratio (year end quote, diluted EPS) - 7.00 19.81 73.40 11.87 13.58 21.56
P/E ratio (year end quote) - 7.00 19.81 73.40 11.87 13.58 21.56
Dividend yield in % 7.59 5.45 3.70 4.84 3.47 2.39 1.87
Equity ratio in % 20.72 28.04 28.81 23.67 34.78 38.18 41.61
Debt ratio in % 70.52 66.26 70.30 75.75 64.27 60.82 57.17

Walgreens Boots Alliance Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Minnix Lanesha 05/31/2024 186,136.00 186,136.00 n/a Buy No
Brown Tracey D 04/22/2024 3,489.00 176,380.00 18.22 Sell No
Brown Tracey D 04/22/2024 11,594.00 179,869.00 n/a Buy No
Bhandari Inderpal S 04/10/2024 3,000.00 3,000.00 18.05 Buy No
Mahajan Manmohan 04/01/2024 6,000.00 166,969.00 19.38 Buy No
Mahajan Manmohan 02/29/2024 101,874.00 160,969.00 n/a Buy No
JARRETT VALERIE B 01/28/2024 4,456.00 4,456.00 22.44 Buy No
SCHLICHTING NANCY M 01/15/2024 15,209.00 n/a 23.05 Sell No
WENTWORTH TIMOTHY C 01/04/2024 10,000.00 585,122.00 24.22 Buy No
Gates Richard P. 11/09/2023 1,000.00 73,929.00 20.45 Sell No
Barra Ornella 10/31/2023 6,235.00 622,563.00 21.08 Sell No
Gates Richard P. 10/31/2023 937.00 74,929.00 21.08 Sell No
Gates Richard P. 10/31/2023 197.00 75,866.00 21.08 Sell No
DRISCOLL JOHN PATRICK 10/31/2023 5,725.00 272,204.00 21.08 Sell No
Gates Richard P. 10/31/2023 244.00 76,063.00 21.08 Sell No
Mahajan Manmohan 10/31/2023 1,517.00 57,609.00 21.08 Sell No
Mahajan Manmohan 10/31/2023 639.00 59,126.00 21.08 Sell No
Mahajan Manmohan 10/31/2023 274.00 59,765.00 21.08 Sell No
May Holly 10/31/2023 1,014.00 191,906.00 21.08 Sell No
Brown Tracey D 10/31/2023 3,024.00 152,243.00 21.08 Sell No
Brown Tracey D 10/31/2023 1,013.00 155,267.00 21.08 Sell No
May Holly 10/31/2023 3,077.00 188,829.00 21.08 Sell No
Gray Danielle 10/31/2023 1,291.00 213,768.00 21.08 Sell No
Gray Danielle 10/31/2023 3,467.00 210,301.00 21.08 Sell No
Heckman Todd 10/31/2023 468.00 27,774.00 21.08 Sell No

Walgreens Boots Alliance Dividend Calendar

Date Name Dividend *yield Currency
2023 Walgreens Boots Alliance Inc 1.92 7.59 USD
2022 Walgreens Boots Alliance Inc 1.91 5.45 USD
2021 Walgreens Boots Alliance Inc 1.88 3.70 USD
2020 Walgreens Boots Alliance Inc 1.84 4.84 USD
2019 Walgreens Boots Alliance Inc 1.78 3.47 USD
2018 Walgreens Boots Alliance Inc 1.64 2.39 USD
2017 Walgreens Boots Alliance Inc 1.53 1.87 USD
2016 Walgreens Boots Alliance Inc 1.46 1.80 USD
2015 Walgreens Boots Alliance Inc 1.37 1.59 USD
2014 Walgreens Boots Alliance Inc 1.28 2.12 USD
2013 Walgreens Boots Alliance Inc 1.14 2.37 USD
2012 Walgreens Boots Alliance Inc 1.00 2.80 USD
2011 Walgreens Boots Alliance Inc 0.80 2.27 USD
2010 Walgreens Boots Alliance Inc 0.63 2.33 USD
2009 Walgreens Boots Alliance Inc 0.50 1.48 USD
2008 Walgreens Boots Alliance Inc 0.40 1.10 USD
2007 Walgreens Boots Alliance Inc 0.33 0.73 USD
2006 Walgreens Boots Alliance Inc 0.27 0.55 USD
2005 Walgreens Boots Alliance Inc 0.22 0.47 USD
2004 Walgreens Boots Alliance Inc 0.18 0.49 USD
2003 Walgreens Boots Alliance Inc 0.16 0.49 USD
2002 Walgreens Boots Alliance Inc 0.15 0.43 USD
2001 Walgreens Boots Alliance Inc 0.14 0.41 USD
2000 Walgreens Boots Alliance Inc 0.14 0.43 USD
1999 Walgreens Boots Alliance Inc 0.13 0.57 USD
*Yield of the Respective Date

Walgreens Boots Alliance Inc Calendar

Event Estimate Info Date
Earnings Report 0.364 USD Q4 2024 Earnings Release 10/10/2024
Earnings Report 0.495 USD Q1 2025 Earnings Release 01/02/2025
Earnings Report 0.636 USD Q2 2025 Earnings Release 03/27/2025
Earnings Report 0.544 USD Q3 2025 Earnings Release 06/26/2025

Walgreens Boots Alliance Inc Past Events

Event Actual EPS Info Date
Earnings Report - Q3 2024 Earnings Release 06/27/2024

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
7
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Walgreens Boots Alliance Shareholder

Owner in %
Freefloat 82.43
Stefano Pessina 16.91
The Vanguard Group, Inc. 9.64
Vanguard Group, Inc. (Subfiler) 9.16
SSgA Funds Management, Inc. 6.29
State Street Corp. 4.20
BlackRock Fund Advisors 3.64
Capital Research & Management Co. (World Investors) 3.37
Vanguard Total Stock Market ETF 2.51
Geode Capital Management LLC 2.19
Vanguard 500 Index Fund 2.13
Invesco QQQ Trust 1.92
BlackRock Institutional Trust Co. NA 1.84
Invesco Capital Management LLC 1.78
Vanguard Mid Cap Index Fund 1.71
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Walgreens Boots Alliance Management

Name Job
Todd Heckman Chief Accounting Officer, SVP & Global Controller
Timothy C. Wentworth Chief Executive Officer & Director
Elizabeth L. Burger Chief Human Resources Officer & Executive VP
Neal Sample Chief Information Officer & Executive VP
Vish Sankaran Chief Innovation Officer
Linh Peters Chief Marketing Officer & Senior Vice President
Luke Rauch Chief Merchandising Officer & Senior VP
Ornella Barra Chief Operating Officer-International
Rick Gates Chief Pharmacy Officer
Jim Townsend Chief Procurement Officer
Bala Visalatha Chief Product Officer & Senior Vice President
Mike Maresca Chief Technology Officer
Anita M. Allemand Chief Transformation & Integration Officer
Thomas E. Polen Director
Stefano Pessina Executive Chairman
Carlos W. Cubia Global Chief Diversity Officer & Senior VP
Manmohan Mahajan Global Chief Financial Officer & EVP
Lanesha T. Minnix Global Chief Legal Officer & Executive VP
Omorlie Harris Global Treasurer & Senior Vice President
Tiffany Kanaga Head-Investor Relations
Inderpal S. Bhandari Independent Director
Bryan C. Hanson Independent Director
Nancy M. Schlichting Independent Director
Robert Huffines Independent Director
Janice May Babiak Independent Director
John Anthony Lederer Independent Director
Valerie B. Jarrett Independent Director
Ginger L. Graham Lead Independent Director
Juan Guerra SVP & Managing Director-International Wholesale
Joseph B. Amsbary Secretary & Senior Vice President
Anas Al-Hamwi Senior Director-Safety & Injury Management
Sebastian Richard Edward James Senior Vice President
Roger Phillips Vice President-Global Mergers & Acquisitions